V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005306 | 290003871 | null | 65.6 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-02 | Cisplatin +Fluorouracil (3 wk) | N | N | 290022751 | EOX |
| 290005307 | 290003871 | 1.65 | 71.4 | Curative (C) | 2015-09-29 | 2015-09-29 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 290022751 | OCTREOTIDE |
| 290005308 | 290003872 | null | null | Adjuvant (A) | 2017-11-13 | 2017-11-21 | Cisplatin +Fluorouracil (3 wk) | 01 | N | 290022757 | LANREOTIDE |
| 290005309 | 290003873 | 1.5 | 53 | null | 2015-03-06 | 2015-03-07 | Cisplatin + Etoposide po&iv 3 day | 02 | null | 290022759 | FLUOROURACIL |
| 290005310 | 290003874 | null | 83.5 | Neo-adjuvant (N) | 2015-03-15 | 2015-04-01 | PLATO Trials | 02 | null | 290022763 | CHOP R |
| 290005311 | 290003875 | 1.71 | 90.4 | Palliative (P) | 2014-04-24 | 2014-04-24 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 290022764 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005312 | 290003876 | null | 110 | Palliative (P) | 2018-01-11 | 2018-01-11 | Trial Unspecified | 02 | Y | 290022766 | SUNITINIB |
| 290005313 | 290003877 | 1.7 | 68.6 | null | 2016-09-19 | 2016-09-25 | Fluorouricil + Folonic Acid (MdG) | null | null | 290022767 | CARBOPLATIN + PACLITAXEL |
| 290005314 | 290003878 | 0 | 79 | Curative (C) | 2015-08-04 | 2015-08-04 | Carboplatin + Etoposide iv&po | 02 | null | 290022768 | OCTREOTIDE |
| 290005315 | 290003879 | 1.75 | 71.5 | null | 2015-03-20 | 2015-03-31 | OCTREOTIDE | 02 | Y | 290022769 | CAPECITABINE |
| 290005316 | 290003880 | 1.78 | 95.6 | null | 2014-08-20 | 2014-08-22 | Docetaxel 75mg/m2 (21 day) | N | null | 290022770 | CAPECITABINE + RT |
| 290005317 | 290003881 | 1.68 | 52.4 | Disease modification (D) | 2013-05-21 | 2013-05-21 | LANREOTIDE | N | N | 290022771 | CETUXIMAB + RT |
| 290005318 | 290003881 | 1.66 | null | Palliative (P) | 2018-02-20 | 2018-03-03 | Capecitabine | N | N | 290022771 | CARBOPLATIN + PEMETREXED |
| 290005319 | 290003881 | 1.69 | 70.3 | Palliative (P) | null | 2016-07-30 | LANREOTIDE | 2 | N | 290022771 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290005320 | 290003881 | 1.56 | 87.6 | Palliative (P) | 2017-06-26 | 2017-06-26 | GemCarbo Days 1+8 | N | N | 290022771 | CISPLATIN + GEMCITABINE |
| 290005321 | 290003882 | null | 61.7 | Curative (C) | null | 2015-02-22 | Capecitabine | N | Y | 290022776 | CETUXIMAB + OXALIPLATIN + MDG |
| 290005322 | 290003883 | null | 65 | null | 2015-12-07 | 2016-01-02 | PACLITAXEL | 02 | Y | 290022780 | IRINOTECAN + MDG |
| 290005323 | 290003884 | 1.88 | 65.1 | Palliative (P) | 2016-01-24 | 2016-02-14 | Cisplatin +Fluorouracil (2 wk) | N | N | 290022781 | CISPLATIN + FLUOROURACIL |
| 290005324 | 290003885 | 1.87 | 64 | Palliative (P) | 2014-09-13 | 2014-09-20 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290026433 | CARBOPLATIN + ETOPOSIDE |
| 290005325 | 290003885 | null | 54.9 | Palliative (P) | 2014-04-09 | 2014-04-28 | CETUXIMAB | N | N | 290026433 | CISPLATIN + FLUOROURACIL + MITOMYCIN |
| 290005326 | 290003886 | 1.6 | 60 | Adjuvant (A) | 2015-01-20 | 2015-01-21 | Capecitabine | N | null | 290000136 | CVP R |
| 290005327 | 290003887 | 1.7 | 67 | Adjuvant (A) | 2018-09-28 | 2018-10-19 | INTERAACT trial | N | N | 290000254 | BEVACIZUMAB |
| 290005328 | 290003888 | 1.63 | 90.8 | Palliative (P) | 2017-03-04 | 2017-03-17 | MCX | 02 | null | 290000359 | CAPECITABINE + RT |
| 290005329 | 290003889 | 2 | null | Curative (C) | 2019-04-09 | 2019-04-13 | Trial Unspecified | N | null | 290000565 | CETUXIMAB |
| 290005330 | 290003890 | null | 73.05 | Adjuvant (A) | 2016-11-22 | 2016-12-07 | CETUXIMAB + RT | N | N | 290000851 | EOF |
| 290005331 | 290003891 | 1.77 | 69 | Palliative (P) | 2017-06-04 | 2017-06-18 | LANREOTIDE | N | N | 290000863 | CETUXIMAB + CISPLATIN + FU |
| 290005332 | 290003891 | 1.64 | 0 | null | 2014-02-15 | 2014-02-20 | Capecitabine 35days + RT | 02 | null | 290000863 | LANREOTIDE |
| 290005333 | 290003892 | 1.63 | 62.7 | Curative (C) | 2015-05-19 | 2015-05-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 290001592 | IPILIMUMAB |
| 290005334 | 290003892 | 1.6 | 60 | Not known (9) | 2018-06-21 | 2018-07-12 | ECX | N | N | 290001592 | CISPLATIN + FLUOROURACIL |
| 290005335 | 290003892 | 1.64 | 86.1 | Palliative (P) | 2018-01-03 | 2018-01-05 | Azacitidine | 02 | N | 290001592 | CAPECITABINE |
| 290005336 | 290003893 | 1.56 | 55 | Palliative (P) | 2015-09-22 | 2015-10-11 | Carboplatin + Etoposide iv&po | N | N | 290001995 | OCTREOTIDE |
| 290005337 | 290003894 | 1.75 | 0 | Neo-adjuvant (N) | 2015-01-06 | 2015-02-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290002278 | CISPLATIN + FLUOROURACIL |
| 290005338 | 290003895 | 1.61 | 66.2 | Palliative (P) | 2019-02-13 | 2019-02-13 | OCTREOTIDE | N | N | 290002606 | CAPECITABINE |
| 290005339 | 290003895 | null | 57.3 | Palliative (P) | 2018-08-31 | 2018-09-01 | CARBOPLATIN + RT | 02 | N | 290002606 | CAPECITABINE |
| 290005340 | 290003896 | 1.78 | 104 | Curative (C) | 2016-03-07 | 2016-03-25 | CTD | N | N | 290003161 | FLUOROURACIL |
| 290005341 | 290003897 | null | 71 | Palliative (P) | 2017-08-06 | 2017-08-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290003235 | CARBOPLATIN |
| 290005342 | 290003898 | null | 65 | Palliative (P) | 2015-07-05 | 2015-07-06 | CHOP R - 21 days | N | N | 290003361 | CAPECITABINE |
| 290005343 | 290003898 | 1.77 | null | Neo-adjuvant (N) | 2014-12-06 | 2015-01-06 | OCTREOTIDE | 02 | Y | 290003361 | LANREOTIDE |
| 290005344 | 290003898 | 1.7 | 70.3 | Palliative (P) | 2017-04-12 | 2017-04-18 | Capecitabine + Cisplatin | N | N | 290003361 | EOX |
| 290005345 | 290003899 | 1.77 | 64 | Curative (C) | null | 2014-07-19 | Docetaxel 75mg/m2 (21 day) | N | N | 290003739 | EOX |
| 290005346 | 290006658 | null | 0 | Palliative (P) | 2016-09-03 | 2016-09-03 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 290003813 | GEMCITABINE |
| 290005347 | 290003900 | 1.74 | 73.7 | Neo-adjuvant (N) | 2014-07-11 | 2014-07-12 | Capecitabine (21days) + Carboplatin | 02 | N | 290003997 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005348 | 290003900 | 1.75 | 0 | Disease modification (D) | 2018-10-13 | 2018-11-09 | Capecitabine 35days + RT | 02 | N | 290003997 | CAPECITABINE + RT |
| 290005349 | 290003900 | 1.55 | 56 | null | 2015-05-05 | 2015-05-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290003997 | CISPLATIN + FLUOROURACIL |
| 290005350 | 290003901 | 1.62 | 108.2 | Palliative (P) | 2016-12-16 | 2016-12-21 | Capecitabine 35days + RT | Y | N | 290004858 | CAPECITABINE |
| 290005351 | 290003902 | null | 53 | Curative (C) | 2017-06-27 | 2017-07-06 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 290004877 | CAPECITABINE |
| 290005352 | 290003903 | 1.48 | null | Adjuvant (A) | 2014-11-17 | 2014-11-19 | Capecitabine 35days + RT | N | N | 290004910 | CISPLATIN + FLUOROURACIL |
| 290005353 | 290003904 | 1.82 | 101 | null | 2017-02-06 | 2017-02-25 | Cetuximab + Radiotherapy Load | N | N | 290005268 | CAPECITABINE + RT |
| 290005354 | 290003904 | 1.7 | 49.8 | Palliative (P) | 2016-10-05 | 2016-10-06 | CAPECITABINE + RT | 2 | N | 290005268 | CARBOPLATIN + PEMETREXED |
| 290005355 | 290003905 | null | 74.3 | null | 2016-11-21 | 2016-11-21 | LANREOTIDE | 2 | N | 290005398 | CAPECITABINE + GEMCITABINE |